The evolution of urban C. difficile infection (CDI): CDI in 2009-2011 is less severe and has better outcomes than CDI in 2006-2008. (Q40205951)

18 September 2017

title

The evolution of urban C. difficile infection (CDI): CDI in 2009-2011 is less severe and has better outcomes than CDI in 2006-2008. (English)

1 reference

18 September 2017

0 references

Clostridium difficile

0 references

author

Paul Feuerstadt

series ordinal

1

0 references

author name string

Rohit Das

series ordinal

2

1 reference

18 September 2017

Lawrence J Brandt

series ordinal

3

1 reference

18 September 2017

language of work or name

English

0 references

publication date

8 July 2014

1 reference

The American Journal of Gastroenterology

18 September 2017

published in

1 reference

18 September 2017

volume

109

1 reference

18 September 2017

issue

8

1 reference

18 September 2017

page(s)

1265-1276

1 reference

Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile

18 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.167

Clostridium difficile colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.167

Narrative review: the new epidemic of Clostridium difficile-associated enteric disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.167

Clostridium difficile--more difficult than ever

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.167

Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.167

Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.167

An epidemic, toxin gene-variant strain of Clostridium difficile

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.167

A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.167

Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.167

Health care-associated Clostridium difficile infection in adults admitted to acute care hospitals in Canada: a Canadian Nosocomial Infection Surveillance Program Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.167

A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.167

Analysis of 30-day mortality for clostridium difficile-associated disease in the ICU setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.167

Thirty-day mortality of Clostridium difficile infection in a UK National Health Service Foundation Trust between 2002 and 2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.167

All-cause and disease-specific mortality in hospitalized patients with Clostridium difficile infection: a multicenter cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.167

Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.167

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.167

Recommendations for surveillance of Clostridium difficile-associated disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.167

Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.167

Clostridium difficile-associated diarrhea and proton pump inhibitor therapy: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.167

Proton pump inhibitor use and recurrent Clostridium difficile-associated disease: a case-control analysis matched by propensity score.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.167

Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.167

Clostridium difficile--associated disease in a setting of endemicity: identification of novel risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.167

Glucocorticoids are associated with increased risk of short-term mortality in hospitalized patients with clostridium difficile-associated disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.167

European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.167

Outcomes of Clostridium difficile-associated disease treated with metronidazole or vancomycin before and after the emergence of NAP1/027.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.167

Reducing the risk of severe complications among patients with Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.167

Clinical factors associated with development of severe-complicated Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.167

Mortality in Clostridium difficile infection: a prospective analysis of risk predictors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.167

Assessment of treatment patterns and patient outcomes before vs after implementation of a severity-based Clostridium difficile infection treatment policy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.167

Clostridium difficile infection: a multicenter study of epidemiology and outcomes in mechanically ventilated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.167

Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.167

Clostridium difficile infection in Europe: a hospital-based survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.167

21 January 2018

Identifiers

DOI

10.1038/AJG.2014.167

1 reference

Dimensions Publication ID

18 September 2017

1051912334

0 references

1 reference